Firma incorporating ‘lived experience’ of patients into home health care training programs

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/Halfpoint)
(Image: Getty/Halfpoint)

Related tags Firma Clinical Research Patient centricity Decentralized trials Clinical trial design Protocol development

Firma Clinical Research collaborates with patient advocates to integrate patient-specific information into its clinical trial patient care partner training program, as the company conducts more procedures in-home 'than ever before.'

Firma Clinical Research provides home health care for clinical trial patients – a service that has been more frequently requested, as sponsors look to take a more patient-centric approach to clinical trials, said the company’s COO, Michael Keens.

In line with this, the company recently collaborated with The Myositis Association (TMA) on a project to incorporate the ‘lived experience’ of patients into training materials for study investigators and nurses.

“These individuals are going into [patient’s] homes, in many cases, over long periods of time. So, the more that they know about the condition that this person suffers from, the better the visit will be,”​ said Keens.

Keens described the program changes as “an opportunity to have the visit be better supported and a better experience for patients.”

The company has since ‘firmed up’ its blueprint to implement the program in other therapeutic areas, developing the survey tools and supplemental training structure.

A better experience

In developing the program, Firma and TMA asked patients: What’s one thing you would want a health care provider to know about you and your disease if they don’t know anything else?

One response described a patient’s need to have full-body support, not just a hand, when getting out of a chair. Keens said this is ‘hugely’ helpful for a home nurse who may need to assist a patient.

“What that provides is an ongoing real-world support example and not a ‘how does this protocol look to you,’”​ said Keens. “It’s the other side of the equation that we can pair with what pharmaceutical companies are doing to make the whole patient experience better.”

According to Keens, sponsors are asking the company to do more in the home than ever before. Today, about 40% of the trials the company supports involve administration of drug – Five years ago, this number would have been ‘very small,’ he said.

“Not only are we seeing pharmaceutical companies and physicians and regulatory authorities getting more comfortable with it – The advent of additional digital scales and digital recording is going to continue to push more and more aspects of protocols in the home,”​ added Keens.

“It’s not just going to sites and having a procedure done,”​ he said, “it’s the patient experience, and by having this additional information on what the patients go through, those visits can become much more embraced by the patients themselves.”

Related news

Show more

Related products

show more

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

Related suppliers

Follow us


View more